Expression of Activity-Dependent Neuroprotective Protein in the Immune System: Possible Functions and Relevance to Multiple Sclerosis
Open Access
- 17 November 2009
- journal article
- research article
- Published by S. Karger AG in Neuroimmunomodulation
- Vol. 17 (2), 120-125
- https://doi.org/10.1159/000258695
Abstract
Background: Activity-dependent neuroprotector (ADNP) is a neuroprotective molecule containing an 8-amino acid peptide, NAPVSIPQ (NAP), that is sufficient for its neuroprotective effects. Objective: To assess the expression of ADNP in the human immune system in normal subjects and multiple sclerosis patients. MaterialsandMethods: ADNP expression was assessed in peripheral blood mononuclear cells (PBMCs) from healthy donors and multiple sclerosis (MS) patients using staining with anti-ADNP (NAP) antibodies and markers for T cells, B cells, monocytes and natural killer cells. ADNP mRNA was determined in peripheral blood from MS patients (n = 24) and matched controls (n = 21). Expression of activation markers CD69 and CD154 and of IFN-γ was assessed by flow cytometry in stimulated PBMCs. Effects of NAP on immune cell proliferation was assessed by tritiated thymidine incorporation. Results: Monocytes, B cells and T cells, but not regulatory (CD4+CD25+) T cells expressed ADNP. NAP peptide decreased the expression of CD69, CD154 and IFN-γ in PBMC and caused suppressed anti-CD3-/anti-CD28-stimulated PBMC proliferation. ADNP mRNA was reduced in MS compared to control peripheral blood. Conclusion: ADNP is expressed in many immune system cells. ADNP mRNA is reduced in PBMCs in MS. The peptide NAP, which plays an important role in neuroprotection, has potential immunomodulatory properties.Keywords
This publication has 18 references indexed in Scilit:
- Immune-Mediated CNS DamagePublished by Springer Science and Business Media LLC ,2009
- The Expression of Activity-Dependent Neuroprotective Protein (ADNP) is Regulated by Brain Damage and Treatment of Mice with the ADNP Derived Peptide, NAP, Reduces the Severity of Traumatic Head InjuryCurrent Alzheimer Research, 2005
- The femtomolar-acting NAP interacts with microtubules: Novel aspects of astrocyte protectionJournal of Alzheimer's Disease, 2005
- Differential regulation of activity-dependent neuroprotective protein in rat astrocytes by VIP and PACAPRegulatory Peptides, 2004
- Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple SclerosisThe Journal of Experimental Medicine, 2004
- A Novel VIP Responsive Gene: Activity Dependent Neuroprotective ProteinAnnals of the New York Academy of Sciences, 2000
- A Novel Signaling Molecule for Neuropeptide Action: Activity‐dependent Neuroprotective ProteinAnnals of the New York Academy of Sciences, 1999
- Proinflammatory cytokines regulate antigen-independent T-cell Activation by two separate calcium-signaling pathways in multiple sclerosis patientsAnnals of Neurology, 1998
- Increased interleukin 12 production in progressive multiple sclerosis: Induction by activated CD4+T cells via CD40 ligandProceedings of the National Academy of Sciences of the United States of America, 1997
- Treatment of multiple sclerosis with gamma interferonNeurology, 1987